TY - JOUR
T1 - Maternal variants in NLRP and other maternal effect proteins are associated with multilocus imprinting disturbance in offspring
AU - Begemann, Matthias
AU - Rezwan, Faisal I
AU - Beygo, Jasmin
AU - Docherty, Louise E.
AU - Kolarova, Julia
AU - Schroeder, Christopher
AU - Buiting, Karin
AU - Chokkalingam, Kamal
AU - Degenhardt, Franziska
AU - Wakeling, Emma L.
AU - Kleinle, Stephanie
AU - Fassrainer, Daniela González
AU - Oehl-Jaschkowitz, Barbara
AU - Turner, Claire L.S.
AU - Patalan, Michal
AU - Gizewska, Maria
AU - Binder, Gerhard
AU - Ngoc, Can Thi Bich
AU - Dung, Vu Chi
AU - Mehta, Sarju G.
AU - Baynam, Gareth
AU - Hamilton-Shield, Julian P.
AU - Aljareh, Sara
AU - Lokulo-Sodipe, Oluwakemi
AU - Horton, Rachel
AU - Siebert, Reiner
AU - Elbracht, Miriam
AU - Temple, Isabel Karen
AU - Eggermann, Thomas
AU - Mackay, Deborah JG
N1 - Funding Information:
Funding MB and te were funded by the german national BMBF (Ministry of education and Science, grant 01gM1513B) and the Deutsche Forschungsgemeinschaft (DFg; grants eg115/10-1 and inSt 948/32-1FUgg). leD and Fir were funded by Medical research council (Mr/J000329/1). KB and JB were funded by the Bundesministerium für Bildung und Forschung (BMBF; imprinting diseases, grant no. 01gM1513a). rS was funded by the german national BMBF (grant no: 01gM1513F). Ol-S was funded by the national institute for Health research (niHr) under its research for Patient Benefit (rfPB) Programme (StaarS UK: grant reference number PB-Pg-1111-26003); iKt is supported by the niHr Biomedical research centre (Brc), Southampton.
Funding Information:
10Praxis für Humangenetik Homburg, Homburg, germany 11Peninsula genetics Service, royal Devon and exeter Hospital, exeter, UK 12Department of Pediatrics, endocrinology, Diabetology, Metabolic Diseases and cardiology, Pomeranian Medical University, Szczecin, Poland 13Pediatric endocrinology, University children’s Hospital, tübingen, germany 14Department of Medical genetics, Metabolism and endocrinology, the national children’s Hospital, Hanoi, Vietnam 15Department of clinical genetics, cambridge University Hospitals trust, cambridge, UK 16School of Paediatrics and child Health, the University of Western australia, Perth, Western australia, australia 17genetic Services of Western australian and Western australian register of Developmental anomalies, Perth, Western australia, australia 18School of clinical Sciences, University of Bristol, Bristol, UK 19Wessex clinical genetics Service, University Hospital, Southampton, UK Acknowledgements the authors acknowledge the expert assistance of the staff of the molecular genetic and epigenetic laboratory of the institute of Human genetics at the University of Kiel, and the support of the iDFOW study by the national institute for Health research (niHr) clinical research network–Wessex, the niHr Southampton Brc and the niHr Wellcome trust Southampton clinical research Facility. DJgM gratefully acknowledges the technical assistance of H cutler.
Funding Information:
MB and TE were funded by the German national BMBF (Ministry of Education and Science, Grant 01GM1513B) and the Deutsche Forschungsgemeinschaft (DFG; Grants EG115/10-1 and INST 948/32-1FUGG). LED and FIR were funded by Medical Research Council (MR/J000329/1). KB and JB were funded by the Bundesministerium für Bildung und Forschung (BMBF; Imprinting diseases, grant no. 01GM1513A). RS was funded by the German national BMBF (grant no: 01GM1513F). OL-S was funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (STAARS UK: Grant Reference Number PB-PG-1111-26003); IKT is supported by the NIHR Biomedical Research Centre (BRC), Southampton.
Publisher Copyright:
© 2018 Article author(s). All rights reserved.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Background: Genomic imprinting results from the resistance of germline epigenetic marks to reprogramming in the early embryo for a small number of mammalian genes. Genetic, epigenetic or environmental insults that prevent imprints from evading reprogramming may result in imprinting disorders, which impact growth, development, behaviour and metabolism. We aimed to identify genetic defects causing imprinting disorders, by whole-exome sequencing in families with one or more members affected by multi-locus imprinting disturbance. Methods: Whole-exome sequencing was performed in 38 pedigrees where probands had multi-locus imprinting disturbance, in five of whom, maternal variants in NLRP5 have previously been found. Results: We now report 15 further pedigrees in which offspring had disturbance of imprinting, while their mothers had rare, predicted-deleterious variants in maternal-effect genes, including NLRP2, NLRP7 and PADI6. As well as clinical features of well-recognised imprinting disorders, some offspring had additional features including developmental delay, behavioural problems and discordant monozygotic twinning, while some mothers had reproductive problems including pregnancy loss. Conclusion: The identification of 20 putative maternal-effect variants in 38 families affected by multi-locus imprinting disorders adds to the evidence that maternal genetic factors affect oocyte fitness and thus offspring development. Testing for maternal-effect genetic variants should be considered in families affected by atypical imprinting disorders.
AB - Background: Genomic imprinting results from the resistance of germline epigenetic marks to reprogramming in the early embryo for a small number of mammalian genes. Genetic, epigenetic or environmental insults that prevent imprints from evading reprogramming may result in imprinting disorders, which impact growth, development, behaviour and metabolism. We aimed to identify genetic defects causing imprinting disorders, by whole-exome sequencing in families with one or more members affected by multi-locus imprinting disturbance. Methods: Whole-exome sequencing was performed in 38 pedigrees where probands had multi-locus imprinting disturbance, in five of whom, maternal variants in NLRP5 have previously been found. Results: We now report 15 further pedigrees in which offspring had disturbance of imprinting, while their mothers had rare, predicted-deleterious variants in maternal-effect genes, including NLRP2, NLRP7 and PADI6. As well as clinical features of well-recognised imprinting disorders, some offspring had additional features including developmental delay, behavioural problems and discordant monozygotic twinning, while some mothers had reproductive problems including pregnancy loss. Conclusion: The identification of 20 putative maternal-effect variants in 38 families affected by multi-locus imprinting disorders adds to the evidence that maternal genetic factors affect oocyte fitness and thus offspring development. Testing for maternal-effect genetic variants should be considered in families affected by atypical imprinting disorders.
KW - Beckwith-Wiedemann syndrome
KW - NLRP2
KW - NLRP5
KW - NLRP7
KW - PADI6
KW - Silver-Russell syndrome
KW - genomic imprinting
KW - multi-locus imprinting disorder
KW - Protein-Arginine Deiminases/genetics
KW - Silver-Russell Syndrome/genetics
KW - Humans
KW - DNA Methylation/genetics
KW - Protein-Arginine Deiminase Type 6
KW - Adaptor Proteins, Signal Transducing/genetics
KW - Female
KW - Chromosomes, Human, Pair 11/genetics
KW - Infant, Newborn
KW - Maternal Inheritance
KW - Beckwith-Wiedemann Syndrome/genetics
KW - Pregnancy
KW - Apoptosis Regulatory Proteins
KW - Genomic Imprinting/genetics
KW - Pedigree
KW - Germ-Line Mutation/genetics
KW - Infant, Newborn, Diseases/genetics
UR - http://www.scopus.com/inward/record.url?scp=85049219275&partnerID=8YFLogxK
U2 - 10.1136/jmedgenet-2017-105190
DO - 10.1136/jmedgenet-2017-105190
M3 - Article
C2 - 29574422
SN - 0022-2593
VL - 55
SP - 497
EP - 504
JO - Journal of Medical Genetics
JF - Journal of Medical Genetics
IS - 7
ER -